Oct 10, 2017 | April Dembosky, Kaiser Health News
California Gov. Jerry Brown signed a sweeping drug price bill that will force drugmakers to publicly justify big price hikes.
Oct 06, 2017 | Susan Morse
Insurer has entered a value-based contract with Collegium Pharmaceutical for the drug Xtampza ER, an oxycodone equivalent with abuse deterrent properties.
Oct 06, 2017 | Jeff Lagasse
Part of the donation will support provider education that promotes best prescribing practices for clinicians who…
Oct 06, 2017 | April Dembosky, Kaiser Health News
The bill, if signed by the California governor, would require drug companies to give notice to state agencies and health…
Stanford, Intermountain partner on opioid project
Oct 04, 2017 | Bernie Monegain
The PCORI-funded study will compare the effectiveness of three approaches to reducing use of the painkillers.
FDA approves lower cost hepatitis C drug
Oct 03, 2017 | Michelle Andrews, Kaiser Health News
Mavyret's price tag of $26,400 for a course of treatment is significantly below that of…
drug prices
Oct 02, 2017 | Jay Hancock, Kaiser Health News
The narrative from PhRMA's publicity campaign is only the rosiest, most self-serving version of pricing say critics.
AIDS program investments would yield returns
Sep 29, 2017 | Jeff Lagasse
Since almost 75 percent of costs are attributable to antiretroviral drug treatment, reducing the price of those drugs…
Sep 27, 2017 | Beth Jones Sanborn
John Gaffney admitted to taking thousands in cash, signing fake prescriptions for pricey compound medications, the…
Novelion subsidiary to pay $35M over risky cholesterol drug
Sep 26, 2017 | Beth Jones Sanborn
Aegerion failed to inform providers of drug's risks outside prescribed usage,…